We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$131M
1-Year Est. Return
46.14%
This Fund
S&P 500
This Quarter
Est. Return
-4.32%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$80.2M
AUM Growth
-$12.3M
(-13%)
Cap. Flow
-$6.04M
Cap. Flow
% of AUM
-7.53%
Top 10 Holdings %
Top 10 Hldgs %
42.03%
Holding
68
New
5
Increased
10
Reduced
20
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regenxbio
RGNX
|
+$1.42M |
| 2 |
VRTU
Virtusa Corporation
VRTU
|
+$1.4M |
| 3 |
APTO
Aptose Biosciences, Inc.
APTO
|
+$1.26M |
| 4 |
CTLP
Cantaloupe
CTLP
|
+$934K |
| 5 |
CSSEP
Chicken Soup for the Soul Entertainment, Inc. Series A Cumulative Redeemable Perpetual Preferred Stock
CSSEP
|
+$748K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATTU
Attunity Ltd
ATTU
|
+$4.58M |
| 2 |
Amplify Alternative Harvest ETF
MJ
|
+$2.22M |
| 3 |
Kratos Defense & Security Solutions
KTOS
|
+$1.83M |
| 4 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$994K |
| 5 |
EverQuote
EVER
|
+$888K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.64% |
| 2 | Healthcare | 20.3% |
| 3 | Communication Services | 16.54% |
| 4 | Consumer Staples | 9.41% |
| 5 | Financials | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AT&T
T
$159B
| $757K | 0.94% |
26,480
-6,620
| -20% | -$175K |
|
27
Ares Capital
ARCC
$13.5B
| $745K | 0.93% |
40,000
| – | – |
|
28
Verizon
VZ
$195B
| $724K | 0.9% |
12,000
| – | – |
|
29
Dow Inc
DOW
$21.9B
| $715K | 0.89% |
15,000
+2,500
| +20% | +$117K |
|
|
CSSEP
30
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Series A Cumulative Redeemable Perpetual Preferred Stock
CSSEP
| $715K | 0.89% |
+29,800
| New | +$748K |
|
31
JPMorgan Chase
JPM
$935B
| $706K | 0.88% |
6,000
| – | – |
|
|
RDS.A
32
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $706K | 0.88% |
12,000
| – | – |
|
33
Microsoft
MSFT
$3.45T
| $695K | 0.87% |
5,000
| – | – |
|
34
Weyerhaeuser
WY
$18B
| $693K | 0.86% |
25,000
| – | – |
|
35
PepsiCo
PEP
$190B
| $686K | 0.86% |
5,000
-500
| -9% | -$66.4K |
|
36
GSK
GSK
$104B
| $683K | 0.85% |
12,800
| – | – |
|
37
BlackRock TCP Capital
TCPC
$273M
| $678K | 0.85% |
50,000
| – | – |
|
38
Apyx Medical
APYX
$173M
| $677K | 0.84% |
100,000
-20,000
| -17% | -$142K |
|
39
Merck
MRK
$322B
| $673K | 0.84% |
8,384
-524
| -6% | -$42K |
|
40
Abbott
ABT
$183B
| $669K | 0.83% |
8,000
-500
| -6% | -$42.5K |
|
41
Carnival Corporation Ltd
CCL
$38.1B
| $656K | 0.82% |
+15,000
| New | +$692K |
|
42
Coca-Cola
KO
$377B
| $653K | 0.81% |
12,000
-1,000
| -8% | -$53.5K |
|
43
Chevron
CVX
$392B
| $652K | 0.81% |
5,500
| – | – |
|
44
Johnson & Johnson
JNJ
$618B
| $647K | 0.81% |
5,000
| – | – |
|
45
Morgan Stanley
MS
$331B
| $640K | 0.8% |
15,000
| – | – |
|
46
ExxonMobil
XOM
$644B
| $635K | 0.79% |
9,000
| – | – |
|
47
Pfizer
PFE
$143B
| $629K | 0.78% |
18,445
+2,635
| +17% | +$95.8K |
|
48
Procter & Gamble
PG
$336B
| $622K | 0.78% |
5,000
-1,500
| -23% | -$177K |
|
49
Altria Group
MO
$114B
| $614K | 0.77% |
15,000
+3,000
| +25% | +$138K |
|
50
Blackstone
BX
$102B
| $611K | 0.76% |
12,500
-2,500
| -17% | -$122K |
|
Similar funds
EIM
CIP
AC
ADEF
LC
EWP
OIM
EPI
P.A.W. Capital's Q3 2019 Portfolio in Review
As of Q3 2019, P.A.W. Capital held 68 positions worth $80.2M, down 13% from $92.5M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
P.A.W. Capital withdrew a net $6.04M in Q3 2019, closing 7 positions and reducing 20 holdings. Its most notable exit was Attunity Ltd, an estimated $4.58M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, P.A.W. Capital opened a new position in Aptose Biosciences, Inc. worth $1.04M.
- P.A.W. Capital's largest Q3 2019 buy was Aptose Biosciences, Inc.: 1,111 shares worth $1.04M.
- P.A.W. Capital added most to Regenxbio in Q3 2019, an estimated $1.42M increase.
- P.A.W. Capital's biggest Q3 2019 reduction was Mandiant, Inc. Common Stock, cutting an estimated $994K.
- P.A.W. Capital fully exited Attunity Ltd in Q3 2019, selling an estimated $4.58M.
- P.A.W. Capital's ten largest holdings make up 42% of its $80.2M portfolio in Q3 2019.
- P.A.W. Capital opened 5 new positions and closed 7 in Q3 2019.
- P.A.W. Capital's portfolio value fell 13% quarter-over-quarter to $80.2M.
Based on P.A.W. Capital's 13F filing for Q3 2019, filed 30 Oct 2019.